Translational Genomics Lab University of Valencia
@GenomicsLab_UV
Our objective is to understand mechanisms of pathogenesis and discover therapeutic targets and innovative treatments for human genetic diseases.
ID:1001821101557723137
https://www.uv.es/gt 30-05-2018 13:42:18
1,8K Tweets
353 Followers
556 Following
Myotonic Dystrophy Foundation is a proud sponsor of the 14th International Myotonic Dystrophy Consortium #IDMC14 ! 🔬🌎 We are excited to learn from & connect with the leading #myotonicDystrophy scientists & researchers from around the globe! idmc14.org
Fantastic presentation by Beatriz Llamusi presenting the excellences of ATX-01 drug candidate for DM1 at #IDMC14 ARTHEx biotech Muscular Dystrophy Association Federación ASEM FEDER | Enfermedades Raras
Puesta de largo de la
RED-DM española en el #IDMC14 Universitat València INCLIVA Muscular Dystrophy Association Federación ASEM FEDER | Enfermedades Raras
Why can RNA only be linear or circular? It can be branched! We made multi-tailed mRNA, and we had fun! Here is our story led by brilliant graduate student Hongyu Chen: rdcu.be/dB7ck and his cartoon illustration👇MIT Chemistry Broad Institute
Great news!! The first SCA1 patient has been dosed with VO659 Radboudumc.
VO659 is an antisense oligonucleotide (ASO) investigational therapy designed by Vico Therapeutics B.V. to target the CAG repeat expansion that causes all known polyglutamine diseases including HD, SCA1 and SCA3!
#RACIBERER2024 Pablo Lapunzina, director científico del CIBERER da la bienvenida al CIBER a los nuevos grupos de #enfermedadesraras liderados por Rubén Artero INCLIVA ; José Manuel Soria Sant Pau - Campus Salut Barcelona; y Rafael Pulido OSI EEC - Hospital Universitario Cruces 👏👏👏
Fortunately, currently, there are more than 35 companies actively researching to find a cure or treatment for #MyotonicDystrophy .
Our hope is that they achieve success soon.
#RareDiseaseDay #DíadelasEnfermedadesRaras
#ComparteTusColores #ShareYourColours
Interesting read: Synthesis and Properties of RNA Modified with Cationic Amine Internucleoside Linkage #oligonucleotides
pubs.acs.org/doi/10.1021/ac…
Finalizamos el Día Internacional de Concienciación sobre la #DistrofiaMiotónica con un libro muy práctico sobre la Distrofia Miotónica Tipo 1, #DM1 o Enfermedad de #Steinert bit.ly/DM1LosHechos
#DíadelasEnfermedadesRaras #RareDiseaseDay
#ComparteTusColores #ShareYourColours
.ARTHEx biotech Receives IND Clearance from the US FDA to Initiate the Phase I-IIa ArthemiR™ Trial of ATX-01 for #MyotonicDystrophy Type 1. Read the full announcement at: arthexbiotech.com/post/arthex-bi…
En Europa la #DistrofiaMiotónica afecta a 1 de cada 11.400 adultos y la Distrofia Miotónica Tipo 1 a 1 de cada 20.000. En el mundo, la Distrofia Miotónica afecta a 1 de cada 15.000 adultos y la Distrofia Miotónica Tipo 1 a 1 de cada 8.000 adultos
#DiadelasEnfermedadesRaras
ℹ️ La Agencia Estatal de Investigación celebrará un webinario para presentar la convocatoria 2023 de ayudas a «Proyectos de Generación de Conocimiento» y a actuaciones para la formación de personal investigador predoctoral asociadas a dichos proyectos.
🗓️ 10 de enero 2024 a las 12:00 h. (Madrid)
🔗…